Underrepresentation of Racial and Ethnic Minorities in Metastatic Colorectal Carcinoma Clinical Trials Within the United States
Strategies are needed to increase minority enrollment in clinical trials for metastatic CRC. Identification of systemic barriers is integral in public policy advocacy to increase representation.
Authors
- Kenneth Luberice (ORCID: https://orcid.org/0000-0002-8065-8405)
- Rebecca A. Snyder (ORCID: https://orcid.org/0000-0002-2485-2481)
- Wei Li (ORCID: https://orcid.org/0000-0002-9692-9820)
- Oliver S. Eng (ORCID: https://orcid.org/0000-0003-0226-5005)
- Tracey Pu (ORCID: https://orcid.org/0000-0001-7880-2183)
- Andrew M. Blakely (ORCID: https://orcid.org/0000-0002-5013-3851)
- Jonathan M. Hernandez
- Alexandra Gustafson
- Sarfraz R. Akmal
Institutions
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Irvine (US)
- University of California, Irvine Medical Center (US)
- National Cancer Institute (US)
- Data Management (Italy) (IT)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1097/sla.0000000000006500
- Citations
- 4
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 2.17